Beigi, A.; Vafaei-Nodeh, S.; Huang, L.; Sun, S.Z.; Ko, J.J.
Survival Outcomes Associated with First and Second-Line Palliative Systemic Therapies in Patients with Metastatic Bladder Cancer. Curr. Oncol. 2021, 28, 3812-3824.
https://doi.org/10.3390/curroncol28050325
AMA Style
Beigi A, Vafaei-Nodeh S, Huang L, Sun SZ, Ko JJ.
Survival Outcomes Associated with First and Second-Line Palliative Systemic Therapies in Patients with Metastatic Bladder Cancer. Current Oncology. 2021; 28(5):3812-3824.
https://doi.org/10.3390/curroncol28050325
Chicago/Turabian Style
Beigi, Arshia, Saba Vafaei-Nodeh, Longlong Huang, Shaun Z. Sun, and Jenny J. Ko.
2021. "Survival Outcomes Associated with First and Second-Line Palliative Systemic Therapies in Patients with Metastatic Bladder Cancer" Current Oncology 28, no. 5: 3812-3824.
https://doi.org/10.3390/curroncol28050325
APA Style
Beigi, A., Vafaei-Nodeh, S., Huang, L., Sun, S. Z., & Ko, J. J.
(2021). Survival Outcomes Associated with First and Second-Line Palliative Systemic Therapies in Patients with Metastatic Bladder Cancer. Current Oncology, 28(5), 3812-3824.
https://doi.org/10.3390/curroncol28050325